JeonjinBio Overview
- Year Founded
-
2004

- Status
-
Public
- Employees
-
39

- Stock Symbol
-
110020

- Share Price
-
$1.76
- (As of Wednesday Closing)
JeonjinBio General Information
Description
JeonJin Bio Co Ltd is a South Korea based company engaged in the manufacturing and sale of pest control product using natural materials and other biotechnology products. It produces biological products including insect repellent, insect direction, algae damage reduction, mammalian damaging agent, parasitic damage reduction agent, pest damage reduction agent, paris segem, breed can, mosquito repellent, and bouquet garni.
Contact Information
Website
www.jjbio.co.krCorporate Office
- Room 403, Venture factory, Daegu Technopark
- 62, Seongseogongdan-ro 11-gil, Dalseo-gu, Daegu
- Daegu, 42713
- South Korea
Corporate Office
- Room 403, Venture factory, Daegu Technopark
- 62, Seongseogongdan-ro 11-gil, Dalseo-gu, Daegu
- Daegu, 42713
- South Korea
JeonjinBio Stock Performance
As of 23-Apr-2025, JeonjinBio’s stock price is $1.76. Its current market cap is $16M with 9.1M shares.
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.76 | $1.75 | $1.40 - $5.56 | $16M | 9.1M | 48.7K | $0.37 |
JeonjinBio Financials Summary
As of 31-Dec-2024, JeonjinBio has a trailing 12-month revenue of $14.1M.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 9,934 | 9,934 | 49,266 | 22,445 |
Revenue | 14,125 | 14,125 | 11,993 | 6,032 |
EBITDA | 4,413 | 4,413 | (2,696) | 120 |
Net Income | 3,185 | 3,185 | (4,925) | (2,409) |
Total Assets | 12,800 | 12,800 | 13,738 | 14,193 |
Total Debt | 63 | 63 | 4,343 | 4,719 |
JeonjinBio Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
JeonjinBio Patents
JeonjinBio Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-2583664-B | Composition for preventing or treating sea lice infections in fish, comprising an extract of sophora flavescens aiton or a fraction thereof | Active | 29-Jan-2018 | ||
GB-2583664-A | Composition for preventing or treating parasitic infections in fish, comprising sophora flavescens aiton extract or fraction thereof | Active | 29-Jan-2018 | ||
GB-202010954-D0 | Composition for preventing or treating parasitic infections in fish, comprimising sophora flavescens aiton extract or fraction thereof | Active | 29-Jan-2018 | ||
CA-3088618-A1 | Compositions for preventing or treating fish parasitic infections, including extracts of sophora flavescens aiton or fractions thereof | Active | 29-Jan-2018 | ||
CA-3088618-C | Compositions for preventing or treating fish parasitic infections, including extracts of sophora flavescens aiton or fractions thereof | Active | 29-Jan-2018 | A61P33/10 |
JeonjinBio Signals
JeonjinBio FAQs
-
When was JeonjinBio founded?
JeonjinBio was founded in 2004.
-
Where is JeonjinBio headquartered?
JeonjinBio is headquartered in Daegu, South Korea.
-
What is the size of JeonjinBio?
JeonjinBio has 39 total employees.
-
What industry is JeonjinBio in?
JeonjinBio’s primary industry is Agricultural Chemicals.
-
Is JeonjinBio a private or public company?
JeonjinBio is a Public company.
-
What is JeonjinBio’s stock symbol?
The ticker symbol for JeonjinBio is 110020.
-
What is the current stock price of JeonjinBio?
As of 23-Apr-2025 the stock price of JeonjinBio is $1.76.
-
What is the current market cap of JeonjinBio?
The current market capitalization of JeonjinBio is $16M.
-
What is JeonjinBio’s current revenue?
The trailing twelve month revenue for JeonjinBio is $14.1M.
-
What is JeonjinBio’s annual earnings per share (EPS)?
JeonjinBio’s EPS for 12 months was $0.37.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »